XML 50 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Share Capital Authorized and Issued
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Share Capital Authorized and Issued
14.          Share Capital Authorized and Issued
The following sets out the number and par value of shares authorized, issued and outstanding:
March 31, 2025December 31, 2024
Common shares, par value $0.01 per share
Authorized600,000,000 600,000,000 
Issued and outstanding
Common shares 110,335,061 111,730,209 
Common shares
Cash dividends of $0.10 per common share were declared and paid in the three months ended March 31, 2025 (2024: $0.10 per common share).
Common share repurchases
On December 21, 2023 and on August 14, 2024, the Board of Directors approved the adoption of common share repurchase programs of up to $50.0 million and up to $200.0 million, respectively, of Fidelis’ outstanding common shares, utilizing a variety of methods, including open market purchases, accelerated share repurchases and privately negotiated transactions.
The following table summarizes common shares repurchased in the three months ended March 31, 2025 and 2024:
Three months ended
March 31, 2025March 31, 2024
Common shares repurchased1,438,278 357,602 
Cost of shares repurchased, inclusive of commissions$22.1 $5.0 
Weighted average price per share, inclusive of commissions$15.37 $13.93 
Of these shares repurchased in the three months ended March 31, 2025, 136,084 (2024: nil) common shares were repurchased from The Fidelis Partnership for $2.1 million (2024: $nil). These transactions were effected at a price equal to the average price paid by the Group on such day for share repurchases from all other shareholders. Common shares repurchased by the Group are held as treasury shares. Common shares repurchased by the Group prior to December 31, 2024 were retired. The unutilized amount of the share repurchase authorization at March 31, 2025, was $122.5 million.